ConductScience.org, home

Paper31333656

Reactivating Immunity Primed by Acellular Pertussis Vaccines in the Absence of Circulating Antibodies: Enhanced Bacterial Control by TLR9 Rather Than TLR4 Agonist-Including Formulation.

Auderset F and 11 others. Front Immunol, 2019. Cited by 15 papers, by iCite.

Cite this record

ConductScience Library. Reactivating Immunity Primed by Acellular Pertussis Vaccines in the Absence of Circulating Antibodies: Enhanced Bacterial Control by TLR9 Rather Than TLR4 Agonist-Including Formulation. Papers, record 31333656. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/31333656

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Reactivating Immunity Primed by Acellular Pertussis Vaccines in the Absence of Circulating Antibodies: Enhanced Bacterial Control by TLR9 Rather Than TLR4 Agonist-Including Formulation.
PubMed
Journal
Front Immunol
PubMed
Year
2019
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
15
iCite
Relative citation ratio, by iCite
0.67
iCite
Revised in PubMed
2020-10-21
PubMed

Authors12

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Auderset FFloriane
2Ballester MMarie
3Mastelic-Gavillet BBeatris
4Fontannaz PPaola
5Chabaud-Riou MMartine
6Reveneau NNathalie
7Garinot MMarie
8Mistretta NNoëlle
9Liu YYuanqing
10Lambert PHPaul-Henri
11Ochs MMartina
12Siegrist CAClaire-Anne

Source PubMed

Download CSV of authors

Topics11

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Adjuvants, ImmunologicMajor topic
Bordetella pertussisMajor topic
Pertussis VaccineMajor topic
Toll-Like Receptor 4Major topic
Toll-Like Receptor 9Major topic
Animals
Antibodies, Bacterial
Female
Mice
Mice, Inbred BALB C
Whooping Cough

Source PubMed

Download CSV of topics

References62

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
110417175Cell-mediated immune responses in four-year-old children after primary immunization with acellular pertussis vaccines.Infect Immun1999https://conductscience.org/library/papers/10417175PubMed
210837200Protection against Bordetella pertussis in mice in the absence of detectable circulating antibody: implications for long-term immunity in children.J Infect Dis2000https://conductscience.org/library/papers/10837200PubMed
311445452Immunity to Bordetella pertussis.Microbes Infect2001https://conductscience.org/library/papers/11445452PubMed
411750224CpG ODN can re-direct the Th bias of established Th2 immune responses in adult and young mice.FEMS Immunol Med Microbiol2001https://conductscience.org/library/papers/11750224PubMed
512385032Bordetella pertussis toxin induces the release of inflammatory cytokines and dendritic cell activation in whole blood: impaired responses in human newborns.Eur J Immunol2002https://conductscience.org/library/papers/12385032PubMed
612467690Pertussis of adults and infants.Lancet Infect Dis2002https://conductscience.org/library/papers/12467690PubMed
712538714Bordetella pertussis infection in 2-month-old infants promotes type 1 T cell responses.J Immunol2003https://conductscience.org/library/papers/12538714PubMed
812835699CpG motifs: the active ingredient in bacterial extracts?Nat Med2003https://conductscience.org/library/papers/12835699PubMed
912960338Toll-like receptor 4-mediated innate IL-10 activates antigen-specific regulatory T cells and confers resistance to Bordetella pertussis by inhibiting inflammatory pathology.J Immunol2003https://conductscience.org/library/papers/12960338PubMed
1015876918Epidemiology of pertussis.Pediatr Infect Dis J2005https://conductscience.org/library/papers/15876918PubMed
1115876927Duration of immunity against pertussis after natural infection or vaccination.Pediatr Infect Dis J2005https://conductscience.org/library/papers/15876927PubMed
1216006019A CpG-containing oligodeoxynucleotide as an efficient adjuvant counterbalancing the Th1/Th2 immune response in diphtheria-tetanus-pertussis vaccine.Vaccine2005https://conductscience.org/library/papers/16006019PubMed
1316818371Immune mechanisms and therapeutic potential of CpG oligodeoxynucleotides.Int Rev Immunol2006https://conductscience.org/library/papers/16818371PubMed
1416863919Induction of dendritic cell maturation by pertussis toxin and its B subunit differentially initiate Toll-like receptor 4-dependent signal transduction pathways.Exp Hematol2006https://conductscience.org/library/papers/16863919PubMed
1517114471TLR4 mediates vaccine-induced protective cellular immunity to Bordetella pertussis: role of IL-17-producing T cells.J Immunol2006https://conductscience.org/library/papers/17114471PubMed
1617116347Modulation of the infant immune responses by the first pertussis vaccine administrations.Vaccine2007https://conductscience.org/library/papers/17116347PubMed
1717494641Lipopolysaccharide analogs improve efficacy of acellular pertussis vaccine and reduce type I hypersensitivity in mice.Clin Vaccine Immunol2007https://conductscience.org/library/papers/17494641PubMed
1817920273The benefits of using diverse animal models for studying pertussis.Trends Microbiol2007https://conductscience.org/library/papers/17920273PubMed
1918498620The role of Toll-like receptor-4 in pertussis vaccine-induced immunity.BMC Immunol2008https://conductscience.org/library/papers/18498620PubMed
2018566386Lipopolysaccharides from Bordetella pertussis and Bordetella parapertussis differently modulate human dendritic cell functions resulting in divergent prevalence of Th17-polarized responses.J Immunol2008https://conductscience.org/library/papers/18566386PubMed

See all 62 referencesDownload CSV of references

Cited by12

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 15 citations.

PMIDTitleJournalYearIn PapersSource
40709171Pertussis resurgence: epidemiological trends, pathogenic mechanisms, and preventive strategies.Front Immunol2025https://conductscience.org/library/papers/40709171PubMed
40475765Avidity of pertussis toxin antibodies following vaccination with genetically versus chemically detoxified pertussis toxin-containing vaccines during pregnancy.Front Immunol2025https://conductscience.org/library/papers/40475765PubMed
39233381Microbiota-immune-brain interactions: A new vision in the understanding of periodontal health and disease.Periodontol 20002024https://conductscience.org/library/papers/39233381PubMed
37651198DNA-Dependent Interferon Induction and Lung Inflammation in Bordetella pertussis Infection.J Interferon Cytokine Res2023https://conductscience.org/library/papers/37651198PubMed
37242993Coping Strategies for Pertussis Resurgence.Vaccines (Basel)2023https://conductscience.org/library/papers/37242993PubMed
36136586The whole-cell pertussis vaccine imposes a broad effector B cell response in mouse heterologous prime-boost settings.JCI Insight2022https://conductscience.org/library/papers/36136586PubMed
35269842Replication-Deficient Lymphocytic Choriomeningitis Virus-Vectored Vaccine Candidate for the Induction of T Cell Immunity against Mycobacterium tuberculosis.Int J Mol Sci2022https://conductscience.org/library/papers/35269842PubMed
35222350Precision Vaccine Development: Cues From Natural Immunity.Front Immunol2021https://conductscience.org/library/papers/35222350PubMed
34097504Triggering Receptor Expressed on Myeloid Cells-1 (TREM-1) Contributes to Bordetella pertussis Inflammatory Pathology.Infect Immun2021https://conductscience.org/library/papers/34097504PubMed
33489011Structure and compositional analysis of aluminum oxyhydroxide adsorbed pertussis vaccine.Comput Struct Biotechnol J2021https://conductscience.org/library/papers/33489011PubMed
33228165Acellular Pertussis Vaccine Inhibits Bordetella pertussis Clearance from the Nasal Mucosa of Mice.Vaccines (Basel)2020https://conductscience.org/library/papers/33228165PubMed
32963814Expanding the role of bacterial vaccines into life-course vaccination strategies and prevention of antimicrobial-resistant infections.NPJ Vaccines2020https://conductscience.org/library/papers/32963814PubMed

Download CSV of cited by

Genes4

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
IFNG3458PubTator's text mininghttps://conductscience.org/library/genes/3458NCBI Gene
IL53567PubTator's text mininghttps://conductscience.org/library/genes/3567NCBI Gene
TLR47099PubTator's text mininghttps://conductscience.org/library/genes/7099NCBI Gene
TLR954106PubTator's text mininghttps://conductscience.org/library/genes/54106NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/31333656

GET https://conductscience.org/api/papers/v1/31333656/references?page=2